Search

Your search keyword '"Joe W. Ramos"' showing total 255 results

Search Constraints

Start Over You searched for: Author "Joe W. Ramos" Remove constraint Author: "Joe W. Ramos"
255 results on '"Joe W. Ramos"'

Search Results

1. RSK1 and RSK2 serine/threonine kinases regulate different transcription programs in cancer

2. Phosphoprotein enriched in astrocytes (PEA)-15 is a novel regulator of adipose tissue expansion

3. RasGRP1 induces autophagy and transformation-associated changes in primary human keratinocytes

4. Progression-free survival of prostate cancer patients is prolonged with a higher regucalcin expression in the tumor tissues: Overexpressed regucalcin suppresses the growth and bone activity in human prostate cancer cells

5. PEA‐15 (Phosphoprotein Enriched in Astrocytes 15) Is a Protective Mediator in the Vasculature and Is Regulated During Neointimal Hyperplasia

6. Extracellular Regucalcin Suppresses the Growth, Migration, Invasion, and Adhesion of Metastatic Human Prostate Cancer Cells

7. Regulation of Leukaemia Associated Rho GEF (LARG/ARHGEF12)

8. Gold(I) Complexes with a Quinazoline Carboxamide Alkynyl Ligand: Synthesis, Cytotoxicity, and Mechanistic Studies

9. The overexpressed transcription factor RGPR-p117 suppresses the proliferation of normal rat kidney proximal tubular epithelial NRK-52E cells: Involvement of diverse signaling pathways

10. PTRH2: an adhesion regulated molecular switch at the nexus of life, death, and differentiation

11. The botanical component p-hydroxycinnamic acid suppresses the growth and bone metastatic activity of human prostate cancer PC-3 cells in vitro

12. Overexpression of regucalcin blocks the migration, invasion, and bone metastatic activity of human prostate cancer cells: Crosstalk between cancer cells and bone cells

13. Proteomics analysis identifies PEA-15 as an endosomal phosphoprotein that regulates α5β1 integrin endocytosis

14. The phytochemical p-hydroxycinnamic acid suppresses the growth and stimulates the death in human liver cancer HepG2 cells

15. Phosphoprotein enriched in astrocytes (PEA)-15 is a novel regulator of adipose tissue expansion

16. Progression-free survival of prostate cancer patients is prolonged with a higher regucalcin expression in the tumor tissues: Overexpressed regucalcin suppresses the growth and bone activity in human prostate cancer cells

17. The calcium channel agonist Bay K 8644 promotes the growth of human liver cancer HepG2 cells in vitro: suppression with overexpressed regucalcin

18. Auranofin-Based Analogues Are Effective Against Clear Cell Renal Carcinoma In Vivo and Display No Significant Systemic Toxicity

19. Englerin a selectively induces necrosis in human renal cancer cells.

20. R-Ras regulates migration through an interaction with filamin A in melanoma cells.

21. Abstract 1218: Targeting B-RAF and checkpoint inhibitor resistant melanoma with RSK inhibitor PMD-026 in pre-clinical models

22. RasGRP1 induces autophagy and transformation-associated changes in primary human keratinocytes

23. Molecular signatures of mu opioid receptor and somatostatin receptor 2 in pancreatic cancer

24. Synthesis of a stable and orally bioavailable englerin analogue

25. Bimetallic titanocene-gold phosphane complexes inhibit invasion, metastasis, and angiogenesis-associated signaling molecules in renal cancer

26. Neopetrocyclamines A and B, Polycyclic Diamine Alkaloids from the Sponge Neopetrosia cf exigua

27. Heterometallic titanium–gold complexes inhibit renal cancer cells in vitro and in vivo

28. RSK2 drives cell motility by serine phosphorylation of LARG and activation of Rho GTPases

29. PEA-15 (phosphoprotein enriched in astrocytes 15) is a protective mediator in the vasculature and is regulated during neointimal hyperplasia

30. PTRH2 gene mutation causes progressive congenital skeletal muscle pathology

31. In Vitro and in Vivo Evaluation of Water-Soluble Iminophosphorane Ruthenium(II) Compounds. A Potential Chemotherapeutic Agent for Triple Negative Breast Cancer

32. Organometallic Titanocene–Gold Compounds as Potential Chemotherapeutics in Renal Cancer. Study of their Protein Kinase Inhibitory Properties

33. Targeted deletion of RasGRP1 impairs skin tumorigenesis

34. RSK Isoforms in Cancer Cell Invasion and Metastasis

35. RSK2 activity mediates glioblastoma invasiveness and is a potential target for new therapeutics

37. Protein Tyrosine Kinase-6 (PTK6)

38. RSK2 Protein Suppresses Integrin Activation and Fibronectin Matrix Assembly and Promotes Cell Migration

39. PEA15 impairs cell migration and correlates with clinical features predicting good prognosis in neuroblastoma

40. PEA-15 potentiates H-Ras-mediated epithelial cell transformation through phospholipase D

41. Stictamides A−C, MMP12 Inhibitors Containing 4-Amino-3-hydroxy-5-phenylpentanoic Acid Subunits

42. Bit-1 Mediates Integrin-dependent Cell Survival through Activation of the NFκB Pathway

43. The death effector domain protein PEA‐15 negatively regulates T‐cell receptor signaling

44. Death Effector Domain-Containing Proteins

45. Abstract 648: Reduced Expression of Phosphoprotein Enriched in Astrocytes-15 (PEA-15) Increases Neointimal Hyperplasia

46. Bit-1 is an essential regulator of myogenic differentiation

47. RSK2 Activity Is Regulated by Its Interaction with PEA-15

48. Abstract 1363: RSK2 provokes invasive signaling in glioblastoma through LARG-dependent activation of Rho GTPases

49. Paper alert: Cell biology

50. Cell Biology

Catalog

Books, media, physical & digital resources